OpenLegislation

Division II.6.6.1.2.2

United Kingdom

Original text. Later amendments are not shown.

Guidance on the need for a pharmacological ADI as provided for in the Committee for Medicinal Products for Veterinary Use (‘CVMP’) guideline on the approach to establish a pharmacological ADIf1 shall be followed. Where no pharmacological ADI is derived, justification for its absence shall be provided.

Annotations

Footnotes

f1

Approach to establish a pharmacological acceptable daily intake (ADI) (http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_001530.jsp&mid=).